AstraZeneca’s new type-2 diabetes drug Kombiglyze may increase a user’s risk of heart failure, pancreatitis, pancreatic cancer, rhabdomyolysis, and other side effects.
Do I Have a Texas Kombiglyze Lawsuit? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was diagnosed with pancreatic cancer, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit.
FDA Evaluating Rhabdomyolysis Risk
The FDA is evaluating a potential signals of a serious risk and new safety information linking DPP4 diabetes drugs and rhabdomyolysis. This potentially life-threatening kidney side effect was identified by the FDA Adverse Event Reporting System (FAERS) between April and June 2017.
What is Kombiglyze?
Kombiglyze XR combines two medications that treat diabetes in different ways — metformin, an extended-release treatment for diabetes, and saxagliptin, a new drug that was introduced in 2009.
Kombiglyze and Pancreatic Cancer
Saxagliptin is an “incretin mimetic,” which means it controls blood-sugar by stimulating the pancreas to make more insulin. One potential risk is pancreatitis (pancreatic inflammation). In March 2013, the FDA announced that it would study the risk of pancreatitis and pancreatic cancer from saxagliptin.
The FDA warning came soon after Diabetes published a study linking incretin mimetic diabetes drugs with pre-cancerous pancreatic tumors. Researchers warned:
“Since the standard of care of a pancreatic neuroendocrine tumor, because of the risk of conversion to malignancy, even if benign, is surgical resection [i.e. removal], patients exposed to incretin therapy would seem to be at increased risk of requiring pancreatic surgery.”
Kombiglyze and Heart Failure
The FDA has also recently warned about a possible increased risk of heart failure from Kombiglyze. The concern was based on results of the SAVOR clinical trial, which linked saxagliptin with a 27% increased risk of hospitalization for heart failure. After the FDA reviewed the study, experts recommended label changes and also warned about a possible increased risk of death.
What is the problem?
The Clark Firm, LLP is nationally recognized as a class action law firm in Texas. However, we are not filing a Kombiglyze class action at this time. Instead, we are filing individual lawsuits and helping people who were diagnosed with pancreatic cancer seek justice.
About Class Actions
Class actions can have disadvantages, especially for people who were injured by severe side effects. Members of class actions may have to accept “low-ball” settlements, higher attorneys’ fees, and never feel like their case got the attention it deserved.
Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Class Action
Class actions are not designed to maximize compensation for individuals with severe injuries. Instead, they are designed to maximize efficiency and help a lot of people resolve similar legal claims all at once.
Instead, our lawyers are filing individual lawsuits. We understand that many of our clients are suffering devastating losses to their physical and financial health, which is why we always review new cases for free. We specialize in helping people who were injured by defective drugs seek compensation for their injury, medical expenses, permanent injuries, and more.
Need a Kombiglyze Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact us for a free Texas Kombiglyze lawsuit review.